Molecular Partners AG (MOLN)

3.87 +0.16 (+4.31%) USD  |  NASDAQ  |  May 16, 16:00
More

Molecular Partners Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for MOLN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2021. Upgrade now.
Date Value
March 31, 2024 --
September 30, 2021 --
Date Value
August 09, 2021 --

Revenue Estimates for Current Quarter Range, Past 5 Years

Upgrade
Minimum
Mar 31 2024
Upgrade
Maximum
Sep 30 2021
Upgrade
Average
Upgrade
Median
Aug 09 2021

Revenue Estimates for Current Quarter Benchmarks

AC Immune SA Upgrade
CRISPR Therapeutics AG Upgrade
Addex Therapeutics Ltd Upgrade
NLS Pharmaceutics Ltd --
MoonLake Immunotherapeutics Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade